about
sameAs
Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.Five dysfunctional telomeres predict onset of senescence in human cellsCARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53Human POT1 facilitates telomere elongation by telomeraseStanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cellsMicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated regionCheck your cultures! A list of cross-contaminated or misidentified cell linesMammalian stanniocalcins and cancerHsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 proteinHuman stanniocalcin (STC): genomic structure, chromosomal localization, and the presence of CAG trinucleotide repeatsThe first molecular details of ALT in human tumor cellsA novel human cDNA highly homologous to the fish hormone stanniocalcinProtein composition of catalytically active human telomerase from immortal cellsThe murine stanniocalcin 2 gene is a negative regulator of postnatal growthCloning and characterization of a novel gene, striamin, that interacts with the tumor suppressor protein p53Identification of a 55-kDa ezrin-related protein that induces cytoskeletal changes and localizes to the nucleolus.Is cell culture a risky business? Risk analysis based on scientist survey data.Telomere biology: a new player in the end zone.Telomere maintenance mechanisms and cellular immortalization.p16(INK4a) and the control of cellular proliferative life span.Constructing immortalized human cell lines.Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences.HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA but not ASF1a.Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers.Alternative lengthening of telomeres in mammalian cells.The murine stanniocalcin 1 gene is not essential for growth and developmentLoss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1.Extreme telomere length dimorphism in the Tasmanian devil and related marsupials suggests parental control of telomere lengthLoss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres.Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres.Telomere maintenance and cancer -- look, no telomerase.Telomerase activity in pleural malignant mesotheliomas.Alternative lengthening of telomeres, telomerase, and cancer.A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase.ATRX represses alternative lengthening of telomeres.Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells.Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblastsAlternative lengthening of telomeres in normal mammalian somatic cells.Detection of alternative lengthening of telomeres by telomere quantitative PCR.
P50
Q24298041-15AF500B-0C13-443B-97FE-4A6FDF5CD7AFQ24299538-D4172157-CC81-425D-9F78-B2D5F3EFE4F2Q24303502-58ADDEE8-C552-4D2F-A688-A1011A933AFEQ24303687-85607389-23C7-497B-9AFE-9842C31AE293Q24532131-706189D3-7DFC-4992-A357-D67A01BF1A0BQ24635277-DA4C2CA3-558A-48C1-9ACA-E2DDC630180BQ27910535-1BE9A549-D5C2-42A1-889E-3C732FB93493Q28204297-D3116566-DD67-402C-98D8-811F6A927E8AQ28207814-27608AA4-EFCD-4218-9F9E-BF917CB69A23Q28263106-465EBC4E-0D9C-48DE-958F-59B6966D414BQ28278615-12E40346-E8AC-4329-8D7C-E733AA814117Q28284398-52DA4B1F-30C9-46F7-B5AA-52B9AE0C4B62Q28295708-F51AD384-98D2-46B7-9BBC-2965D97F4FFFQ28505295-4992F836-D53E-460C-9AF8-D0436907C4A8Q28594467-D55328D9-E959-4D72-A1E8-B2096472428DQ30725639-8F10BB6C-3307-4536-936E-97823DE1E7D4Q30993308-0DC6207C-1F89-4EC2-9556-143F86B84E55Q31122616-18FEC3A4-2F30-4E1D-9351-3C85AAFF1208Q33540084-0C5FCC5D-D3E5-4C0F-8136-5B1ABAA3C059Q33652119-C02AC1C3-4B99-4B32-9117-2DE828F55D9AQ33744858-94F74D6C-E7F9-4E20-8C1B-DE5545B52728Q33815938-91B75F05-0687-4EF5-A6EB-B9C314CC1C84Q33828273-1713E2DC-76E4-4DF2-9E07-2F1880376F5EQ34031757-8D12C8FD-AE0C-4EEE-9AC0-C17C9D8E0E10Q34114656-C9178D1F-F6DE-4CCF-BDF1-C4D44EFE8760Q34150823-17770484-0FBE-4552-8F72-08F42F19AE95Q34350929-2AA75362-0DB5-4F69-AB3A-5C8E6BEA8C83Q34431404-FCEAB160-E7CF-4096-8278-30C2F3AC91C0Q34438663-FC2D7879-B697-4A59-B780-B5B5C768EDE4Q34490971-03159286-3AEE-4095-A105-DA476BD8734DQ34662153-644C680F-467D-4406-858A-529443EA2551Q34988280-90AEAD8C-B0C3-4E94-9C77-23DF6792B95EQ35103570-51D96A2A-DB33-4572-8838-04B284DE3E2EQ35131772-975459CB-53C6-4CD7-9217-F4F4157F369CQ35131772-B8E62492-13C9-4259-BE62-ABB868C56FB9Q35656649-6713FE1A-4BA1-40C3-BE72-23B9960DD839Q36140856-4F48ADDF-852C-45EF-AFC5-70818466EC60Q36455904-7BBC7B90-50BB-480A-A254-7308D94F3B6DQ36554262-B384ABF4-9170-4B8E-A690-56DD812C7278Q36557062-0A9CD9BD-9F7C-4E13-97B2-20F0665E959D
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Roger R Reddel
@nl
Roger R Reddel
@sl
Roger R. Reddel
@en
Roger R. Reddel
@es
type
label
Roger R Reddel
@nl
Roger R Reddel
@sl
Roger R. Reddel
@en
Roger R. Reddel
@es
altLabel
Roger R Reddel
@en
Roger Reddel
@en
prefLabel
Roger R Reddel
@nl
Roger R Reddel
@sl
Roger R. Reddel
@en
Roger R. Reddel
@es
P214
P106
P1153
7005411135
P21
P214
P31
P496
0000-0002-6302-6107
P735
P7859
viaf-93484854